http://bit.ly/2AbPxuj

The stock was up 5 per cent at Rs 436 on the BSE in intra-day trade after its US subsidiary Taro Pharmaceutical reported strong results for the quarter ended December 2018.

from Markets http://bit.ly/2DYk5SA

Comments

Popular posts from this blog

MPL accuses ASCI of 'tampering' with ads